{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:50:53Z","timestamp":1780599053917,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007312","name":"National Center for Geriatrics and Gerontology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS056872"],"award-info":[{"award-number":["R01 NS056872"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 NS106356"],"award-info":[{"award-number":["R21 NS106356"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007857","name":"Intellectual and Developmental Disabilities Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014761","name":"Hope Center for Neurological Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.nbd.2019.104615","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T19:29:05Z","timestamp":1570649345000},"page":"104615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex"],"prefix":"10.1016","volume":"134","author":[{"given":"Bo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Rensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nbd.2019.104615_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12816","article-title":"Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentation","volume":"28","author":"Anastasaki","year":"1995","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.nbd.2019.104615_bb0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0387-7604(94)00118-H","article-title":"Sleep disorders in tuberous sclerosis: a polysomnographic study","volume":"17","author":"Bruni","year":"1995","journal-title":"Brain Dev."},{"key":"10.1016\/j.nbd.2019.104615_bb0015","first-page":"81","article-title":"The hypocretin\/orexin system in sleep disorders: preclinical insights and clinical progress","volume":"8","author":"Chow","year":"2016","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.nbd.2019.104615_bb0020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pcl.2015.03.005","article-title":"Tuberous sclerosis complex","volume":"62","author":"DiMario","year":"2015","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.nbd.2019.104615_bb0025","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1528-1167.2007.01110.x","article-title":"The natural history and treatment of epilepsy in a murine model of tuberous sclerosis","volume":"48","author":"Erbayat-Altay","year":"2007","journal-title":"Epilepsia."},{"key":"10.1016\/j.nbd.2019.104615_bb0030","first-page":"155","article-title":"Genetic determinants of sleep regulation in inbred mice","volume":"22","author":"Franken","year":"1999","journal-title":"Sleep."},{"key":"10.1016\/j.nbd.2019.104615_bb0035","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1158\/0008-5472.CAN-04-2487","article-title":"Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo","volume":"64","author":"Fraser","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.nbd.2019.104615_bb0040","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2019.104615_bb0045","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/sleep\/26.8.953","article-title":"Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog","volume":"26","author":"Fujiki","year":"2003","journal-title":"Sleep."},{"key":"10.1016\/j.nbd.2019.104615_bb0050","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","article-title":"Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant","volume":"79","author":"Herring","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2019.104615_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2788.1993.tb00868.x","article-title":"Development, behaviour and seizures in 300 cases of tuberous sclerosis","volume":"37","author":"Hunt","year":"1993","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.nbd.2019.104615_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1469-8749.1994.tb11819.x","article-title":"Sleep disorder and epilepsy in children with tuberous sclerosis: a questionnaire-based study","volume":"36","author":"Hunt","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.nbd.2019.104615_bb0065","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1528-1167.2005.00289.x","article-title":"Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes","volume":"46","author":"Jansen","year":"2005","journal-title":"Epilepsia."},{"key":"10.1016\/j.nbd.2019.104615_bb0070","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/ar.22641","article-title":"Quantitative analysis of histological staining and fluorescence using ImageJ","volume":"296","author":"Jensen","year":"2013","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.nbd.2019.104615_bb0075","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2019.104615_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fphar.2014.00016","article-title":"Hypocretin (orexin) regulation of sleep-to-wake transitions","volume":"5","author":"de Lecea","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104615_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1474-4422(14)70218-2","article-title":"Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy","volume":"14","author":"Liblau","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2019.104615_bb0090","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.celrep.2017.07.008","article-title":"Aberrant proteostasis of BMAL1 underlies circadian abnormalities in a paradigmatic mTOR-opathy","volume":"20","author":"Lipton","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.104615_bb0095","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.104615_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2019.104615_bb0105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1460-9568.2000.00919.x","article-title":"The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats","volume":"12","author":"Piper","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104615_bb0110","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.psc.2015.07.002","article-title":"The neurobiology of sleep and wakefulness","volume":"38","author":"Schwartz","year":"2015","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.nbd.2019.104615_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.peptides.2016.12.008","article-title":"Increased plasma orexin-A levels in patients with insomnia disorder are not associated with prepro-orexin or orexin receptor gene polymorphisms","volume":"88","author":"Tang","year":"2017","journal-title":"Peptides."},{"key":"10.1016\/j.nbd.2019.104615_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10283","article-title":"Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures","volume":"52","author":"Uhlmann","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104615_bb0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13023-018-0901-8","article-title":"TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study","volume":"13","author":"de Vries","year":"2018","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.nbd.2019.104615_bb0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/bph.12261","article-title":"Discovery and development of orexin receptor antagonists as therapeutics for insomnia","volume":"171","author":"Winrow","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104615_bb0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","article-title":"Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies","volume":"51","author":"Wong","year":"2010","journal-title":"Epilepsia."},{"key":"10.1016\/j.nbd.2019.104615_bb0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.10648","article-title":"Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model","volume":"54","author":"Wong","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104615_bb0145","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.104615_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2010.05.003","article-title":"TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis","volume":"224","author":"Zhang","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2019.104615_bb0155","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/epi.13923","article-title":"Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner","volume":"58","author":"Zou","year":"2017","journal-title":"Epilepsia."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119302906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119302906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:48:54Z","timestamp":1778518134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119302906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":31,"alternative-id":["S0969996119302906"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104615","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104615"}}